Brief: Conmed Corp - Announces Exit From Gastroenterology Product Lines
Dec 5 (Reuters) - Conmed Corp CNMD.N: CONMED CORP - ANNOUNCES EXIT FROM GASTROENTEROLOGY PRODUCT LINES CONMED CORP - COMPANY EXPECTS EPS DILUTION OF $0.45-$0.55 IN 2026 CONMED CORP - REAFFIRMS 2025 REVENUE AND EPS GUIDANCE CONMED CORP: FINANCIAL TERMS OF AGREEMENT WERE NOT DISCLOSED Source text: ID:nBw9vdjPna Further company coverage: CNMD.N ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Conmed
See all newsU.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Conmed Corp reports results for the quarter ended June 30 - Earnings Summary
Conmed Q2 sales, adjusted profit beat on organinc platform growth
Brief: Conmed Q2 Adjusted EPS USD 1.38 Vs. IBES Estimate USD 1.11
Brief: Conmed Is Said To Weigh Sale After Takeover Interest- Bloomberg News